Vladimir Zakharov explains how DataFrames serve as a vital tool for data-oriented programming in the Java ecosystem. By ...
A brand-name drug is the original version of a medication that’s FDA-approved to treat a specific condition. Generics contain exact copies of the active ingredient in the original branded drug (an ...
Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Ozempic in March after Novo Nordisk AS's patent for the drug expires. That would make the Indian drugmaker one of the first ...
Indian drugmaker Dr Reddy’s Laboratories Ltd is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March after the drug’s patent expiry, becoming one of the first firms to capture ...
There are some languages that don't need mass appeal to be loved. Elixir, Lua, Zig, Clojure, Julia, and Rust prove that point ...
Sun Pharmaceutical has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection, the company said, as it joins domestic ...
Novartis said it expected a key profitability metric to decline this year in large part due to increased competition in the U.S. from generic drug competitors. The Swiss pharma major said Wednesday ...
WE wish to express our support for the recent statements made by Health Minister Datuk Seri Dr Dzulkefly Ahmad regarding the National Generic Medicines Framework. The announcement that Malaysia has ...
Heart failure is a pressing worldwide public-health problem with millions of patients having worsening heart failure. Despite all the available therapies, the condition carries a very poor prognosis.
At the stroke of midnight on New Year’s Eve, Danish drugmaker Novo Nordisk recorded another milestone in Canada: for the fourth year in a row, its blockbuster drug Ozempic was the highest-earning ...
Several interactions that occur between tumour necrosis factor (TNF) superfamily members have gained prominence based on studies of animal models of immune function and disease. The interactions ...